REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Laboratorios Seres S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing
Full name: Laboratorios Seres S.A.S. Profile Updated: August 07, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorios Seres S.A.S. is based in Colombia. The head office is in Cali. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on June 24, 1993. It currently has a total number of 12 (2024) employees. The latest financial highlights indicate a net sales revenue drop of 31.54% in 2023. A negative growth of 4.74% was recorded in its total assets.

Headquarters
Cra 29A1 10A 85
Cali; Valle del Cauca;

Contact Details: Purchase the Laboratorios Seres S.A.S. report to view the information.

Website: http://laboratoriosseres.com

Basic Information
Total Employees:
Purchase the Laboratorios Seres S.A.S. report to view the information.
Outstanding Shares:
Purchase the Laboratorios Seres S.A.S. report to view the information.
Registered Capital:
Purchase the Laboratorios Seres S.A.S. report to view the information.
Incorporation Date:
June 24, 1993
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Laboratorios Seres S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-31.54%▼
Total operating revenue
-31.54%▼
Operating profit (EBIT)
-57.48%▼
Net Profit (Loss) for the Period
N/A
Total assets
-4.74%▼
Total equity
-34.97%▼
Operating Profit Margin (ROS)
-4.34%▼
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
-0.46%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo